Like any good millennial, Mahlon Randolph spends a lot of time on his smartphone. And when a little red notification bubble pops up on his screen, he pays attention.
“I’ll be like: ‘What’s that in there?,’” Randolph said on a recent weekday morning, sitting on a couch in his apartment in Decatur. “Then I’m like: ‘Oh, I gotta take my medicine.’”
That medicine is an antiretroviral drug called Biktarvy, and Randolph takes it to reduce the amount of HIV in his blood. He tested positive for the virus in 2014 when he was in college.
Read this story for free
To continue reading, sign up for our newsletters and get unlimited access to WABE.org
We won't share your information with outside organizations Why am I seeing this?
